A detailed history of Savant Capital, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 18,674 shares of NTRA stock, worth $3.13 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,674
Previous 18,260 2.27%
Holding current value
$3.13 Million
Previous $1.98 Million 20.03%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$97.75 - $129.67 $40,468 - $53,683
414 Added 2.27%
18,674 $2.37 Million
Q2 2024

Aug 05, 2024

BUY
$85.28 - $112.6 $1.01 Million - $1.33 Million
11,827 Added 183.85%
18,260 $1.98 Million
Q1 2024

May 03, 2024

BUY
$59.21 - $92.9 $380,897 - $597,625
6,433 New
6,433 $588,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.